A citation-based method for searching scientific literature

Anne Vincent-Salomon, Carlo Lucchesi, Nadège Gruel, Virginie Raynal, Gaëlle Pierron, Rémi Goudefroye, Fabien Reyal, François Radvanyi, Rémy Salmon, Jean-Paul Thiery, Xavier Sastre-Garau, Brigitte Sigal-Zafrani, Alain Fourquet, Olivier Delattre. Clin Cancer Res 2008
Times Cited: 111







List of co-cited articles
975 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution.
D Craig Allred, Yun Wu, Sufeng Mao, Iris D Nagtegaal, Sangjun Lee, Charles M Perou, Syed K Mohsin, Peter O'Connell, Anna Tsimelzon, Dan Medina. Clin Cancer Res 2008
202
30

Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
30

Gene expression profiles of human breast cancer progression.
Xiao-Jun Ma, Ranelle Salunga, J Todd Tuggle, Justin Gaudet, Edward Enright, Philip McQuary, Terry Payette, Maria Pistone, Kimberly Stecker, Brian M Zhang,[...]. Proc Natl Acad Sci U S A 2003
620
29

Breast cancer precursors revisited: molecular features and progression pathways.
Maria A Lopez-Garcia, Felipe C Geyer, Magali Lacroix-Triki, Caterina Marchió, Jorge S Reis-Filho. Histopathology 2010
187
26

Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection.
Lucia Hernandez, Paul M Wilkerson, Maryou B Lambros, Adriana Campion-Flora, Daniel Nava Rodrigues, Arnaud Gauthier, Cecilia Cabral, Vidya Pawar, Alan Mackay, Roger A'Hern,[...]. J Pathol 2012
109
25

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
23

Progression from ductal carcinoma in situ to invasive breast cancer: revisited.
Catherine F Cowell, Britta Weigelt, Rita A Sakr, Charlotte K Y Ng, James Hicks, Tari A King, Jorge S Reis-Filho. Mol Oncol 2013
133
23

Classification of ductal carcinoma in situ by gene expression profiling.
Juliane Hannemann, Arno Velds, Johannes B G Halfwerk, Bas Kreike, Johannes L Peterse, Marc J van de Vijver. Breast Cancer Res 2006
117
22

Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways.
H Buerger, F Otterbach, R Simon, C Poremba, R Diallo, T Decker, L Riethdorf, C Brinkschmidt, B Dockhorn-Dworniczak, W Boecker. J Pathol 1999
245
22

Regulation of in situ to invasive breast carcinoma transition.
Min Hu, Jun Yao, Danielle K Carroll, Stanislawa Weremowicz, Haiyan Chen, Daniel Carrasco, Andrea Richardson, Shelia Violette, Tatiana Nikolskaya, Yuri Nikolsky,[...]. Cancer Cell 2008
360
20


Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
Laura C Collins, Rulla M Tamimi, Heather J Baer, James L Connolly, Graham A Colditz, Stuart J Schnitt. Cancer 2005
170
19

Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.
Karla Kerlikowske, Annette M Molinaro, Mona L Gauthier, Hal K Berman, Fred Waldman, James Bennington, Henry Sanchez, Cynthia Jimenez, Kim Stewart, Karen Chew,[...]. J Natl Cancer Inst 2010
231
19

Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer.
Aslaug Aamodt Muggerud, Michael Hallett, Hilde Johnsen, Kristine Kleivi, Wenjing Zhou, Simin Tahmasebpoor, Rose-Marie Amini, Johan Botling, Anne-Lise Børresen-Dale, Therese Sørlie,[...]. Mol Oncol 2010
80
21

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.
Christina Curtis, Sohrab P Shah, Suet-Feung Chin, Gulisa Turashvili, Oscar M Rueda, Mark J Dunning, Doug Speed, Andy G Lynch, Shamith Samarajiwa, Yinyin Yuan,[...]. Nature 2012
17

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Lawrence J Solin, Robert Gray, Frederick L Baehner, Steven M Butler, Lorie L Hughes, Carl Yoshizawa, Diana B Cherbavaz, Steven Shak, David L Page, George W Sledge,[...]. J Natl Cancer Inst 2013
315
16

Molecular evolution of breast cancer.
Peter T Simpson, Jorge S Reis-Filho, Theodora Gale, Sunil R Lakhani. J Pathol 2005
338
15

Molecular markers in ductal carcinoma in situ of the breast.
Dale Porter, Jaana Lahti-Domenici, Aparna Keshaviah, Young Kyung Bae, Pedram Argani, Jeffrey Marks, Andrea Richardson, Amiel Cooper, Robert Strausberg, Gregory J Riggins,[...]. Mol Cancer Res 2003
208
15

Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas.
Els C Robanus-Maandag, Cathy A J Bosch, Petra M Kristel, Augustinus A M Hart, Ian F Faneyte, Petra M Nederlof, Johannes L Peterse, Marc J van de Vijver. J Pathol 2003
78
19

Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression.
Jun Yao, Stanislawa Weremowicz, Bin Feng, Robert C Gentleman, Jeffrey R Marks, Rebecca Gelman, Cameron Brennan, Kornelia Polyak. Cancer Res 2006
127
15

Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma.
Clint E Johnson, Kylie L Gorringe, Ella R Thompson, Ken Opeskin, Samantha E Boyle, Yuker Wang, Prue Hill, G Bruce Mann, Ian G Campbell. Breast Cancer Res Treat 2012
48
31


Patterns of chromosomal alterations in breast ductal carcinoma in situ.
E Shelley Hwang, Sandy DeVries, Karen L Chew, Dan H Moore, Karla Kerlikowske, Ann Thor, Britt-Marie Ljung, Frederic M Waldman. Clin Cancer Res 2004
92
15

Single-cell genetic analysis of ductal carcinoma in situ and invasive breast cancer reveals enormous tumor heterogeneity yet conserved genomic imbalances and gain of MYC during progression.
Kerstin Heselmeyer-Haddad, Lissa Y Berroa Garcia, Amanda Bradley, Clarymar Ortiz-Melendez, Woei-Jyh Lee, Rebecca Christensen, Sheila A Prindiville, Kathleen A Calzone, Peter W Soballe, Yue Hu,[...]. Am J Pathol 2012
73
19

Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes.
H Buerger, F Otterbach, R Simon, K L Schäfer, C Poremba, R Diallo, C Brinkschmidt, B Dockhorn-Dworniczak, W Boecker. J Pathol 1999
182
13

Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.
Koei Chin, Sandy DeVries, Jane Fridlyand, Paul T Spellman, Ritu Roydasgupta, Wen-Lin Kuo, Anna Lapuk, Richard M Neve, Zuwei Qian, Tom Ryder,[...]. Cancer Cell 2006
906
13

On the origin and progression of ductal carcinoma in the human breast.
S R Wellings, H M Jensen. J Natl Cancer Inst 1973
262
13


Repeated observation of breast tumor subtypes in independent gene expression data sets.
Therese Sorlie, Robert Tibshirani, Joel Parker, Trevor Hastie, J S Marron, Andrew Nobel, Shibing Deng, Hilde Johnsen, Robert Pesich, Stephanie Geisler,[...]. Proc Natl Acad Sci U S A 2003
13

Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease.
S E Clark, J Warwick, R Carpenter, R L Bowen, S W Duffy, J L Jones. Br J Cancer 2011
83
15

Intraductal carcinoma of the breast: follow-up after biopsy only.
D L Page, W D Dupont, L W Rogers, M Landenberger. Cancer 1982
477
12


Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer.
Rulla M Tamimi, Heather J Baer, Jonathan Marotti, Mark Galan, Laurie Galaburda, Yineng Fu, Anne C Deitz, James L Connolly, Stuart J Schnitt, Graham A Colditz,[...]. Breast Cancer Res 2008
217
12

Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.
D Craig Allred, Stewart J Anderson, Soonmyung Paik, D Lawrence Wickerham, Iris D Nagtegaal, Sandra M Swain, Elefetherios P Mamounas, Thomas B Julian, Charles E Geyer, Joseph P Costantino,[...]. J Clin Oncol 2012
193
12

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
Nina Bijker, Philip Meijnen, Johannes L Peterse, Jan Bogaerts, Irène Van Hoorebeeck, Jean-Pierre Julien, Massimiliano Gennaro, Philippe Rouanet, Antoine Avril, Ian S Fentiman,[...]. J Clin Oncol 2006
435
11

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.
Christos Sotiriou, Pratyaksha Wirapati, Sherene Loi, Adrian Harris, Steve Fox, Johanna Smeds, Hans Nordgren, Pierre Farmer, Viviane Praz, Benjamin Haibe-Kains,[...]. J Natl Cancer Inst 2006
11

Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci.
P O'Connell, V Pekkel, S A Fuqua, C K Osborne, G M Clark, D C Allred. J Natl Cancer Inst 1998
258
11

Tiling path genomic profiling of grade 3 invasive ductal breast cancers.
Rachael Natrajan, Maryou B Lambros, Socorro María Rodríguez-Pinilla, Gema Moreno-Bueno, David S P Tan, Caterina Marchió, Radost Vatcheva, Sydonia Rayter, Betania Mahler-Araujo, Laura G Fulford,[...]. Clin Cancer Res 2009
129
11

Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
Anna Bergamaschi, Young H Kim, Pei Wang, Therese Sørlie, Tina Hernandez-Boussard, Per E Lonning, Robert Tibshirani, Anne-Lise Børresen-Dale, Jonathan R Pollack. Genes Chromosomes Cancer 2006
358
11

Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
Christina S Schuetz, Michael Bonin, Susan E Clare, Kay Nieselt, Karl Sotlar, Michael Walter, Tanja Fehm, Erich Solomayer, Olaf Riess, Diethelm Wallwiener,[...]. Cancer Res 2006
178
11

Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors.
Mona L Gauthier, Hal K Berman, Caroline Miller, Krystyna Kozakeiwicz, Karen Chew, Dan Moore, Joseph Rabban, Yunn Yi Chen, Karla Kerlikowske, Thea D Tlsty. Cancer Cell 2007
169
11

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
370
11

The natural history of ductal carcinoma in situ of the breast: a review.
Bircan Erbas, Elena Provenzano, Jane Armes, Dorota Gertig. Breast Cancer Res Treat 2006
210
11

Gene amplification in ductal carcinoma in situ of the breast.
L Burkhardt, T J Grob, I Hermann, E Burandt, M Choschzick, F Jänicke, V Müller, C Bokemeyer, R Simon, G Sauter,[...]. Breast Cancer Res Treat 2010
53
20

Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer.
Sangjun Lee, Sheila Stewart, Iris Nagtegaal, Jingqin Luo, Yun Wu, Graham Colditz, Dan Medina, D Craig Allred. Cancer Res 2012
106
11

A Molecular Portrait of High-Grade Ductal Carcinoma In Situ.
Martin C Abba, Ting Gong, Yue Lu, Jaeho Lee, Yi Zhong, Ezequiel Lacunza, Matias Butti, Yoko Takata, Sally Gaddis, Jianjun Shen,[...]. Cancer Res 2015
77
14

Gene-expression signatures in breast cancer.
Christos Sotiriou, Lajos Pusztai. N Engl J Med 2009
956
10

The molecular portraits of breast tumors are conserved across microarray platforms.
Zhiyuan Hu, Cheng Fan, Daniel S Oh, J S Marron, Xiaping He, Bahjat F Qaqish, Chad Livasy, Lisa A Carey, Evangeline Reynolds, Lynn Dressler,[...]. BMC Genomics 2006
967
10

Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.
Fabrice Andre, Bastien Job, Philippe Dessen, Attila Tordai, Stefan Michiels, Cornelia Liedtke, Catherine Richon, Kai Yan, Bailang Wang, Gilles Vassal,[...]. Clin Cancer Res 2009
243
10

Supervised risk predictor of breast cancer based on intrinsic subtypes.
Joel S Parker, Michael Mullins, Maggie C U Cheang, Samuel Leung, David Voduc, Tammi Vickery, Sherri Davies, Christiane Fauron, Xiaping He, Zhiyuan Hu,[...]. J Clin Oncol 2009
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.